Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Schizophrenia

Free Subscription 30.03.2026 2 Br J Psychiatry 1 J Clin Psychiatry 2 Mol Psychiatry 1 Neuropsychopharmacology 2 Psychiatry Res 1 Psychol Med 8 Schizophr Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Br J Psychiatry

1. WU X, Lu C, Kong H, Chen R, et al
   Recalibrating the epigenetic clock reveals divergent DNA methylation age signatures across schizophrenia, bipolar disorder and major depressive disorder.
   Br J Psychiatry. 2026 Mar 25:1-9. doi: 10.1192/bjp.2025.10508.
   PubMed         Abstract available
   
   
2. JULIA L, Ortiz-Garcia de la Foz V, Gonzalez-Segura A, Alemany M, et al
   Predicting early clinical recovery in first-episode psychosis: development and external validation of a clinically interpretable multivariable model.
   Br J Psychiatry. 2026 Mar 23:1-12. doi: 10.1192/bjp.2026.10581.
   PubMed         Abstract available
   
   

   
   J Clin Psychiatry

3. RAMIREZ J, Correll CU
   Life After Clozapine: Managing Treatment-Resistant Schizophrenia When Clozapine Is No Longer an Option.
   J Clin Psychiatry. 2026;87:26ac16364.
   PubMed        
   
   

   
   Mol Psychiatry

4. ZHANG S, Chen Y, Zhang L, Yang X, et al
   Global lifetime prevalence of schizophrenia: A systematic review and meta-analysis.
   Mol Psychiatry. 2026 Mar 23. doi: 10.1038/s41380-026-03533.
   PubMed         Abstract available
   
   
5. DAMIANI S, Stefanelli R, Fortea L, D'Imperio A, et al
   Interventions for negative symptoms in schizophrenia: efficacy and clinical interpretability in a meta-analysis of 451 randomized controlled trials.
   Mol Psychiatry. 2026 Mar 23. doi: 10.1038/s41380-026-03543.
   PubMed         Abstract available
   
   

   
   Neuropsychopharmacology

6. QI G, Zhang Y, Wang YL, Anjum F, et al
   Putative glymphatic function and free water in schizophrenia: A 7T DTI study across psychosis stages.
   Neuropsychopharmacology. 2026 Mar 24. doi: 10.1038/s41386-026-02391.
   PubMed         Abstract available
   
   

   
   Psychiatry Res

7. LUTHER L, Barolette JT, Patron C, Howell E, et al
   Discrepancies between ideal and actual affect predict negative symptoms in schizophrenia in daily life: An ecological momentary assessment study.
   Psychiatry Res. 2026;360:117087.
   PubMed         Abstract available
   
   
8. LI Y, Ding X
   Letter to editor regarding "Cognition in schizophrenia across phases of illness: A systematic review and meta-analysis".
   Psychiatry Res. 2026;360:117094.
   PubMed        
   
   

   
   Psychol Med

9. WANG M, Zhu GH, Yang J, Fu XW, et al
   Differential impacts of audiovisual information on empathic accuracy in people with schizophrenia and high social anhedonia.
   Psychol Med. 2026;56:e72.
   PubMed         Abstract available
   
   

   
   Schizophr Res

10. BAGALI K, Uppinkudru C, Pathak H, Parlikar R, et al
    Corrigendum to "Aberrant motor cortical plasticity in antipsychotic-resistant schizophrenia: A cross-sectional study using transcranial direct current and magnetic stimulation" [Schizophr. Res., volume 290 (2026), pages 48-56].
    Schizophr Res. 2026 Mar 25:S0920-9964(26)00097.
    PubMed        
    
    
11. KONSTAS K, Gupta T
    Blunted affect in schizophrenia.
    Schizophr Res. 2026;293:32-38.
    PubMed         Abstract available
    
    
12. BLACKMAN G, Bell V
    Secondary psychosis revisited: Advancing detection, assessment and treatment.
    Schizophr Res. 2026;293:30-31.
    PubMed        
    
    
13. POLETTI M, Preti A, Raballo A
    Duration of Active Attenuated Psychosis (DAAP): Extending time-based illness modelling to the clinical high-risk state.
    Schizophr Res. 2026;293:27-29.
    PubMed        
    
    
14. CROWLEY P, Boland F, Thompson A, McGorry P, et al
    The duration of active psychosis and relationship with early psychosis outcomes.
    Schizophr Res. 2026;293:17-26.
    PubMed         Abstract available
    
    
15. DAZZAN P, Torous J
    Introducing the new "Innovation and Technology Section" in Schizophrenia Research.
    Schizophr Res. 2026 Mar 25:S0920-9964(26)00098.
    PubMed        
    
    
16. RICCI V, Chiappini S, Martinotti G, Maina G, et al
    From substance-induced psychosis to schizophrenia: Predictors of treatment response and transition to chronic psychotic illness-A systematic review.
    Schizophr Res. 2026 Mar 24:S0920-9964(26)00062.
    PubMed         Abstract available
    
    
17. LYNCH ST, Renard KB, Chaia AI, Cohen LJ, et al
    Aripiprazole two-month long-acting injectable may increase time to readmission compared to aripiprazole one-month in patients with schizophrenia and schizoaffective disorder.
    Schizophr Res. 2026;293:1-7.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum